Product
SVF
3 clinical trials
7 indications
Indication
Diabetes MellitusIndication
Type 2Indication
Platelet-rich PlasmaIndication
SVFIndication
Tracheoesophageal FistulaIndication
Bronchial FistulaIndication
Thumb arthritisClinical trial
Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treatment of Type 2 DiabetesStatus: Completed, Estimated PCD: 2017-12-01
Clinical trial
A Pilot Study: Evaluating the Safety and Feasibility of Using Autologous Adipose-Derived Stromal Vascular Fraction (SVF) for the Treatment of Aerodigestive & Enterocutaneous Fistulae in AdultsStatus: Withdrawn, Estimated PCD: 2027-02-01
Clinical trial
Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of RhizarthrosisStatus: Not yet recruiting, Estimated PCD: 2025-04-01